Several previous studies have nicely demonstrated that reduced amount of H2AX increases DNA damage and sensitivity to anti‐cancer therapies (Bassing et al, 2003; Celeste et al, 2003; Meador et al, 2008; Revet et al, 2011). Here, H2AX is linked to cancer.